Trial Profile
A study to evaluate everolimus blood concentration on its anti-cancer activity in patients with metastatic renal cell carcinoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 04 Dec 2015 New trial record